Literature DB >> 33289046

[2020 ESC guidelines on atrial fibrillation : Summary of the most relevant recommendations and innovations].

Alireza Sepehri Shamloo1, Nikolaos Dagres2, Gerhard Hindricks2.   

Abstract

The new guidelines for the diagnosis and management of atrial fibrillation (AF) were published by the European Society of Cardiology (ESC) in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) in August 2020. The 2020 guidelines of the ESC on AF summarize the current developments in this field and provide general recommendations for the management of patients with AF based on the principles of evidence-based medicine. Beside the general statements on definition, epidemiology and clinical features of AF, interesting new aspects in screening and diagnosis of AF are also presented. The main novelties of the 2020 guidelines are the proposal of the 4S-AF scheme for a structured characterization of AF that takes the stroke risk, severity of symptoms, severity of AF burden and substrate severity into account. Also new is the ABC approach for improvement of the structured management and treatment results. A further innovation is the introduction of the concept of major risk factors for recurrences in the decision for catheter ablation. This review focuses on the newest and most important recommendations taken from the 2020 ESC guidelines for the diagnosis and management of AF.

Entities:  

Keywords:  Anticoagulation; Atrial fibrillation; Cardiac arrhythmias; Catheter ablation; Recommendations; Stroke prevention

Mesh:

Year:  2021        PMID: 33289046     DOI: 10.1007/s00059-020-05005-y

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  23 in total

1.  Smart Watch Devices for Atrial Fibrillation Screening: It Has to Start Somewhere.

Authors:  Alireza Sepehri Shamloo; Andreas Bollmann; Nikolaos Dagres; Arash Arya; Gerhard Hindricks
Journal:  J Am Coll Cardiol       Date:  2020-03-24       Impact factor: 24.094

2.  The ABC pathway: an integrated approach to improve AF management.

Authors:  Gregory Y H Lip
Journal:  Nat Rev Cardiol       Date:  2017-09-29       Impact factor: 32.419

Review 3.  Challenges in the classification of atrial fibrillation.

Authors:  Steven A Lubitz; Emelia J Benjamin; Jeremy N Ruskin; Valentin Fuster; Patrick T Ellinor
Journal:  Nat Rev Cardiol       Date:  2010-06-22       Impact factor: 32.419

Review 4.  A review of factors associated with maintenance of sinus rhythm after elective electrical cardioversion for atrial fibrillation.

Authors:  Veronika Ecker; Charles Knoery; Gordon Rushworth; Ian Rudd; Astrid Ortner; David Begley; Stephen J Leslie
Journal:  Clin Cardiol       Date:  2018-06-07       Impact factor: 2.882

Review 5.  Rate control in atrial fibrillation.

Authors:  Isabelle C Van Gelder; Michiel Rienstra; Harry J G M Crijns; Brian Olshansky
Journal:  Lancet       Date:  2016-08-20       Impact factor: 79.321

6.  Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation.

Authors:  Gregory Y H Lip; Robby Nieuwlaat; Ron Pisters; Deirdre A Lane; Harry J G M Crijns
Journal:  Chest       Date:  2009-09-17       Impact factor: 9.410

7.  European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population.

Authors:  Jens Cosedis Nielsen; Yenn-Jiang Lin; Marcio Jansen de Oliveira Figueiredo; Alireza Sepehri Shamloo; Alberto Alfie; Serge Boveda; Nikolaos Dagres; Dario Di Toro; Lee L Eckhardt; Kenneth Ellenbogen; Carina Hardy; Takanori Ikeda; Aparna Jaswal; Elizabeth Kaufman; Andrew Krahn; Kengo Kusano; Valentina Kutyifa; Han S Lim; Gregory Y H Lip; Santiago Nava-Townsend; Hui-Nam Pak; Gerardo Rodríguez Diez; William Sauer; Anil Saxena; Jesper Hastrup Svendsen; Diego Vanegas; Marmar Vaseghi; Arthur Wilde; T Jared Bunch; Alfred E Buxton; Gonzalo Calvimontes; Tze-Fan Chao; Lars Eckardt; Heidi Estner; Anne M Gillis; Rodrigo Isa; Josef Kautzner; Philippe Maury; Joshua D Moss; Gi-Byung Nam; Brian Olshansky; Luis Fernando Pava Molano; Mauricio Pimentel; Mukund Prabhu; Wendy S Tzou; Philipp Sommer; Janice Swampillai; Alejandro Vidal; Thomas Deneke; Gerhard Hindricks; Christophe Leclercq
Journal:  Europace       Date:  2020-08-01       Impact factor: 5.214

8.  The PROFID project.

Authors:  Nikolaos Dagres; Niels Peek; Christophe Leclercq; Gerhard Hindricks
Journal:  Eur Heart J       Date:  2020-10-14       Impact factor: 29.983

9.  The European Heart Rhythm Association symptom classification for atrial fibrillation: validation and improvement through a simple modification.

Authors:  Gareth J Wynn; Derick M Todd; Matthew Webber; Laura Bonnett; James McShane; Paulus Kirchhof; Dhiraj Gupta
Journal:  Europace       Date:  2014-02-16       Impact factor: 5.214

10.  Paroxysmal atrial fibrillation recurrences and quality of life in symptomatic patients: A crossover study of flecainide and pilsicainide.

Authors:  Tsuyoshi Shiga; Koichiro Yoshioka; Eiichi Watanabe; Hisako Omori; Masahiro Yagi; Yasuo Okumura; Naoki Matsumoto; Kengo Kusano; Chikara Oshiro; Takanori Ikeda; Naohiko Takahashi; Takashi Komatsu; Atsushi Suzuki; Tsuyoshi Suzuki; Yasuto Sato; Takeshi Yamashita
Journal:  J Arrhythm       Date:  2017-05-17
View more
  2 in total

1.  Sex Differences in Epicardial Adipose Tissue: Association With Atrial Fibrillation Ablation Outcomes.

Authors:  Jing Zhu; Kaimin Zhuo; Bo Zhang; Zhen Xie; Wenjia Li
Journal:  Front Cardiovasc Med       Date:  2022-06-13

2.  Efficacy and safety of vernakalant for cardioversion of recent-onset atrial fibrillation: A protocol for systematic review and meta-analysis.

Authors:  Hong Li; Yi Liang; Xuejing Song; Wu-Sha Liu-Huo; Wen Chen; Chao Tang; Lizhi Zhao; Xue Bai
Journal:  Medicine (Baltimore)       Date:  2022-03-11       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.